Peptide yy (pyy) for inducing glucose responsiveness in pancreatic islets
CA 2360324 C · Owner: Lu, Kuang-Hui · Inventors: Pang, Kevin; Lu, Kuang-Hui
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to methods for potentiating enhancing or restoring , glucose , responsivity in pancreatic islets or cells. For example the disclosure , describes Peptide yY (PYY) and related peptides that stimulate glucose nonresponsive pancreatic .beta. cells to produce , insulin in response to glucose. The compositions can be used as therapies for diseases caused , by, or coincident with aberrant glucose metabolism, such as Type II Diabetes Mellitus, insulin resistance, glucose intolerance glucose non-responsiveness, hyperglycemia or , obesity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 10, 2000 and granted March 29, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 10, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 10, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.